Comparing 2 hypotheses side-by-side
**Molecular Mechanism and Rationale** TAR DNA-binding protein 43 (TDP-43), encoded by the TARDBP gene, is a nuclear ribonucleoprotein that plays crucial roles in RNA metabolism, including transcriptional repression, pre-mRNA splicing, and mRNA stability regulation. The protein consists of two RNA recognition motifs (RRM1 and RRM2), a nuclear localization signal, and a C-terminal glycine-rich domain (GRD) spanning amino acids 274-414. Under pathological conditions, TDP-43 undergoes cytoplasmic m
**Molecular Mechanism and Rationale** The TAR DNA-binding protein 43 (TDP-43), encoded by the TARDBP gene, serves as a critical RNA-binding protein (RBP) that orchestrates complex post-transcriptional regulatory networks essential for neuronal homeostasis. Under physiological conditions, TDP-43 functions as a master regulator of cryptic exon silencing through its preferential binding to UG-rich and GU-rich sequences located within introns and 3' untranslated regions of target transcripts. The p
| Dimension | Glycine-Rich Domain Competitiv | Cryptic Exon Silencing Restora |
|---|---|---|
| Mechanistic | 0.650 | 0.750 |
| Evidence | 0.550 | 0.700 |
| Novelty | 0.700 | 0.650 |
| Feasibility | 0.450 | 0.600 |
| Impact | 0.600 | 0.720 |
| Druggability | 0.500 | 0.580 |
| Safety | 0.400 | 0.550 |
| Competition | 0.750 | 0.680 |
| Data | 0.600 | 0.750 |
| Reproducible | 0.450 | 0.620 |
4 rounds · quality: 0.54
# Novel Therapeutic Hypotheses for TDP-43 Phase Separation in ALS-FTD ## Hypothesis 1: Arginine Methylation Enhancement Therapy **Target:** PRMT1/CARM1 (Protein Arginine Methyltransferases) **Descri...
# Novel Therapeutic Hypotheses for TDP-43 Phase Separation in ALS-FTD ## Hypothesis 1: Arginine Methylation Enhancement Therapy **Target:** PRMT1/CARM1 (Protein Arginine Methyltransferases) **Descri...
# Critical Evaluation of TDP-43 Phase Separation Therapeutic Hypotheses ## Hypothesis 1: Arginine Methylation Enhancement Therapy ### Specific Weaknesses: 1. **Oversimplified mechanism**: The hypoth...
# Critical Evaluation of TDP-43 Phase Separation Therapeutic Hypotheses ## Hypothesis 1: Arginine Methylation Enhancement Therapy ### Specific Weaknesses: 1. **Oversimplified mechanism**: The hypoth...
4 rounds · quality: 0.68
# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...
# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...
# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...
# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...
6 paper(s) cited by multiple hypotheses — shared evidence strengthens or challenges convergent claims.
| Paper | Cited By |
|---|---|
| Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Biomolecules 2026 | |
| Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Protein Molecules (Basel, Switzerland) 2026 | |
| Axonal transport impairment as an upstream mechanism in amyotrophic lateral scle Frontiers in neuroscience 2026 | |
| The Genetics of TDP-43 Type C Neurodegeneration: A Whole-Genome Sequencing Study Neurology. Genetics 2026 | |
| Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanism. Brain communications 2026 | |
| Credibility analysis of putative disease-causing genes using bioinformatics. PloS one 2013 |